Literature DB >> 18040852

Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role(s) of cytokines and nitric oxide.

Prati Pal Singh1, Priya Singal.   

Abstract

Opioid modulation of host resistance to infectious diseases is well documented; however, not much is known during visceral leishmaniasis (VL). Low doses of morphine, administered subcutaneously in Leishmania donovani-infected BALB/c mice, on days 0 and +15, significantly (p < 0.05) suppressed (1 mg/kg/day) or even sterile-cleared (2 mg/kg/day) the infection; paradoxically, high doses (10 and 30 mg/kg/day) exacerbated the infection. In vitro, low concentration (1 x 10(-9) and 1 x 10(-11) M) morphine treatment of L. donovani-infected mouse peritoneal macrophages (PM), endowed them with significant (p < 0.05) leishmanicidal activity, whereas a high-concentration (1 x 10(-5) M) treatment augmented intramacrophage parasite growth. Naloxone pre-treatment of infected-mice (4 mg/kg x 2) and of infected-PM (1 x 10(-5) M), blocked only the morphine low dose/concentration-induced protective effect. The splenocytes from protected mice and morphine low concentration-treated infected-PM, elaborated significantly (p < 0.05) enhanced levels of interleukin-12, interferon-gamma, tumor necrosis factor-alpha, granulocyte-macrophage colony-stimulating factor and nitrite in the culture medium; a high dose/concentration suppressed their elaboration. Curiously, only morphine high dose/concentration-treated infected mice splenocytes and infected PM, produced significantly (p < 0.05) increased quantity of transforming growth factor-beta1. Aminoguanidine, significantly (p < 0.05) blocked the morphine low dose/concentration-induced protective effect, in vivo and in vitro. This first study demonstrates dose-dependent biphasic modulatory effects of morphine in L. donovani-infected mice and PM, in vitro, apparently via nitric oxide-dependent mechanisms. These results thus demonstrate the implications of opiate abuse on the efficacy assessment of antileishmanial drugs and vaccines, and on the reactivation of latent VL in areas where both drug abuse and VL are rampant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040852     DOI: 10.1007/s11481-007-9094-y

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   7.285


  79 in total

Review 1.  Opiates and infection.

Authors:  J M Risdahl; K V Khanna; P K Peterson; T W Molitor
Journal:  J Neuroimmunol       Date:  1998-03-15       Impact factor: 3.478

Review 2.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  Morphine modulates NF kappa B activation in macrophages.

Authors:  S Roy; K J Cain; R B Chapin; R G Charboneau; R A Barke
Journal:  Biochem Biophys Res Commun       Date:  1998-04-17       Impact factor: 3.575

4.  Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates.

Authors:  R Pacifici; G Patrini; I Venier; D Parolaro; P Zuccaro; E Gori
Journal:  J Pharmacol Exp Ther       Date:  1994-06       Impact factor: 4.030

5.  Visceral leishmaniasis and AIDS.

Authors:  M de Gorgolas; M A Miles
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

6.  Pharmacokinetics and cytokine production in heroin and morphine-treated mice.

Authors:  R Pacifici; S di Carlo; A Bacosi; S Pichini; P Zuccaro
Journal:  Int J Immunopharmacol       Date:  2000-08

7.  Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages.

Authors:  X Peng; D M Mosser; M W Adler; T J Rogers; J J Meissler; T K Eisenstein
Journal:  J Leukoc Biol       Date:  2000-11       Impact factor: 4.962

8.  Morphine increases susceptibility to oral Salmonella typhimurium infection.

Authors:  A S MacFarlane; X Peng; J J Meissler; T J Rogers; E B Geller; M W Adler; T K Eisenstein
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

Review 9.  Prediction of the role of granulocyte-macrophage colony-stimulating factor in animals and man from in vitro results.

Authors:  E Liehl; J Hildebrandt; C Lam; P Mayer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

10.  Immunomodulation by morphine in Plasmodium berghei-infected mice.

Authors:  P P Singh; S Singh; G P Dutta; R C Srimal
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

View more
  15 in total

1.  Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection.

Authors:  Jessica M Breslow; M Alexandra Monroy; John M Daly; Joseph J Meissler; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-09       Impact factor: 4.147

2.  Potentiating effect of morphine on oral Salmonella enterica serovar Typhimurium infection is μ-opioid receptor-dependent.

Authors:  Jessica M Breslow; Pu Feng; Joseph J Meissler; John E Pintar; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  Microb Pathog       Date:  2010-08-03       Impact factor: 3.738

Review 3.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

Review 4.  Role of the mu-opioid receptor in opioid modulation of immune function.

Authors:  Jana Ninković; Sabita Roy
Journal:  Amino Acids       Date:  2011-12-15       Impact factor: 3.520

Review 5.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

Review 6.  Interactions between morphine and nitric oxide in various organs.

Authors:  Noboru Toda; Shiroh Kishioka; Yoshio Hatano; Hiroshi Toda
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

7.  Regulation of mu opioid receptor expression in developing T cells.

Authors:  Lily Zhang; Judith Sliker Belkowski; Tammi Briscoe; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-25       Impact factor: 4.147

8.  Effect of morphine on Mycobacterium smegmatis infection in mice and macrophages.

Authors:  Raman Preet Singh; Sarbjit Singh Jhamb; Prati Pal Singh
Journal:  Indian J Microbiol       Date:  2009-08-20       Impact factor: 2.461

9.  A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit.

Authors:  Geraldine De Muylder; Kenny K H Ang; Steven Chen; Michelle R Arkin; Juan C Engel; James H McKerrow
Journal:  PLoS Negl Trop Dis       Date:  2011-07-19

10.  A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern Iran.

Authors:  Mohammad Reza Aflatoonian; Iraj Sharifi; Maryam Hakimi Parizi; Ali Reza Fekri; Behnaz Aflatoonian; Maryam Sharifi; Ahmad Khosravi; Ali Khamesipour; Hamid Sharifi
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.